Oxycodone and Qmiiz odt drug interactions - a phase IV clinical study of FDA data
Summary:
We study 162,602 people who take Oxycodone (oxycodone hydrochloride) and Qmiiz odt (meloxicam). There is no drug interaction reported.
The study analyzes what interactions people have when they take Oxycodone and Qmiiz odt. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Oxycodone?
Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.
What is Qmiiz odt?
Qmiiz odt has active ingredients of meloxicam. eHealthMe is studying from 10 Qmiiz odt users. Check the latest studies of Qmiiz odt.
No report is found.
Do you take Oxycodone and Qmiiz odt?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride and meloxicam (the active ingredients of Oxycodone and Qmiiz odt, respectively), and Oxycodone and Qmiiz odt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amoxicillin cause Cataract? - 5 seconds ago
- Could Xeloda cause Quality Of Life Decreased? - 9 seconds ago
- Rheumatoid Arthritis and Osteoporosis - 9 seconds ago
- Could Versed cause Oxygen Saturation Decreased? - 10 seconds ago
- Could Sodium Bicarbonate cause Respiratory Distress? - 11 seconds ago
- Could Tegretol cause Sepsis? - 11 seconds ago
- Could Cialis cause Aseptic Necrosis? - 16 seconds ago
- Could Yervoy cause Tachycardia Aggravated? - 20 seconds ago
- Drug interactions of Oxycontin and Cyclobenzaprine Hydrochloride - 21 seconds ago
- Drug interactions of Xalatan and Lyrica - 21 seconds ago